We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published

News   May 08, 2015

 
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
 
 
 

RELATED ARTICLES

Protein Switches Sides in Leukemia

News

Researchers have discovered that an epigenetic protein called EZH2 delays the development of acute myeloid leukemia (AML) but then switches sides once the disease is established to help maintain tumor growth.

READ MORE

3D Mammography Significantly Reduces Breast Biopsy Rates

News

The use of digital breast tomosynthesis (DBT), also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study published in the journal Radiology.

READ MORE

Study Ties Common Heartburn Medications to Kidney Disease

News

Common medications prescribed to treat heartburn, acid reflux and ulcers are linked to increased risks for kidney failure and chronic kidney disease, found a recent University at Buffalo study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE